Avadel Pharmaceu lost $0.51 per diluted share in fiscal year 2024. This represents an increase of 74.5% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to $0.00 per diluted share. The table below carries 15 fiscal years, from 2010 to 2024, and the quarters Avadel Pharmaceu has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Avadel Pharmaceu's diluted earnings per share in fiscal year 2024?
Avadel Pharmaceu lost $0.51 per diluted share in fiscal year 2024.
How fast is Avadel Pharmaceu's diluted earnings per share growing?
Avadel Pharmaceu (AVDL) diluted earnings per share rose by 74.5% year over year, from -$2.00 to -$0.51 in fiscal year 2024.
What is Avadel Pharmaceu's diluted earnings per share over the last twelve months?
Avadel Pharmaceu (AVDL) reported $0.00 per diluted share over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
How has Avadel Pharmaceu's diluted earnings per share changed over the years?
Across the 15 fiscal years this page covers, Avadel Pharmaceu (AVDL) diluted earnings per share went from -$0.37 in fiscal year 2010 to -$0.51 in fiscal year 2024.
What was Avadel Pharmaceu's diluted earnings per share in the most recent quarter?
Avadel Pharmaceu (AVDL) reported $0.00 in diluted earnings per share in Q3 2025. This represents an increase of 100.0% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Avadel Pharmaceu (AVDL) reported on that line in every period on record.
